Detalhe da pesquisa
1.
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.
Ann Intern Med
; 168(7): 461-470, 2018 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29459949
2.
Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients-An analysis from the Brazilian Hodgkin Lymphoma Registry.
Int J Cancer
; 142(5): 883-890, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29023692
3.
Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry.
Hematol Oncol
; 36(1): 189-195, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28643458
4.
Deep molecular responses achieved in patients with CML-CP who are switched to nilotinib after long-term imatinib.
Blood
; 124(5): 729-36, 2014 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-24948656
5.
Cytokine profile of patients with chronic immune thrombocytopenia affects platelet count recovery after Helicobacter pylori eradication.
Br J Haematol
; 168(3): 421-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25257094
6.
BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival.
Cancer Invest
; 2015 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26279306
7.
BCR-ABL mutations in chronic myeloid leukemia treated with tyrosine kinase inhibitors and impact on survival.
Cancer Invest
; 33(9): 451-8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26288116
8.
Chronic lymphocytic leukemia in Brazil: A retrospective analysis of 1903 cases.
Am J Hematol
; 92(8): E171-E173, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28474845
9.
The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia.
Haematologica
; 96(10): 1560-4, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21972211
10.
The duration of the use of imatinib mesylate is only weakly related to elevated BNP levels in chronic myeloid leukaemia patients.
Hematol Oncol
; 29(3): 124-30, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20860069
11.
Long-term treatment-free remission in patients with chronic myeloid leukemia after second-line nilotinib: ENESTop 5-year update.
Leukemia
; 35(6): 1631-1642, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33980976
12.
IL1RN VNTR and IL2-330 polymorphic genes are independently associated with chronic immune thrombocytopenia.
Br J Haematol
; 150(6): 679-84, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20626741
13.
An evaluation of the cardiotoxicity of imatinib mesylate.
Leuk Res
; 32(12): 1809-14, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18495246
14.
De novo acute myeloid leukemia in adults younger than 60 years of age: socioeconomic aspects and treatment results in a Brazilian university center.
Leuk Lymphoma
; 47(8): 1557-64, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16966267
15.
Guideline on myeloproliferative neoplasms: Associacão Brasileira de Hematologia, Hemoterapia e Terapia Cellular: Project guidelines: Associação Médica Brasileira - 2019.
Hematol Transfus Cell Ther
; 41 Suppl 1: 1-73, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31248788
16.
The serum levels of the cytokines involved in the Th17 and Th1 cell commitment are increased in individuals with borderline thrombocytopenia.
J Hematol Oncol
; 6: 28, 2013 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23587441
17.
The use of imatinib mesylate has no adverse effects on the heart function. Results of a pilot study in patients with chronic myeloid leukemia.
Leuk Res
; 35(3): 317-22, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20692037
18.
Granulocytic sarcoma of the stomach: relapse after hematopoietic stem-cell transplantation for chronic myeloid leukemia.
Hematol Oncol Stem Cell Ther
; 3(2): 94-8, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20543544
19.
Long-term effect of Helicobacter pylori eradication on plasma homocysteine in elderly patients with cobalamin deficiency.
Gut
; 56(4): 469-74, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17005765
20.
Transplante alogênico de células-tronco hematopoéticas em leucemias agudas: a experiência de dez anos do Hospital das Clínicas da UFMG / Allogeneic hematopoietic stem cells transplantation in acute leukemia: ten years of experience in the Hospital das Clínicas
Rev. bras. hematol. hemoter
; 32(2): 108-115, 2010. graf, tab
Artigo
em Português
| LILACS | ID: lil-553489